Michael Sinclair - 06 Jun 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Director, 10%+ Owner
Signature
/s/ Michael Sinclair
Issuer symbol
N/A
Transactions as of
06 Jun 2022
Net transactions value
-$109,771
Form type
4
Filing time
08 Jun 2022, 16:39:12 UTC
Previous filing
06 Jun 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale $99,483 -7,688 -16% $12.94 41,532 06 Jun 2022 Direct
transaction OPNT Common Stock Sale $10,288 -800 -1.9% $12.86 40,732 07 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.